SER
Serina Therapeutics Inc
NYSE MKT: SER · HEALTHCARE · BIOTECHNOLOGY
$1.83
-1.08% today
Updated 2026-04-29
Market cap
$27.26M
P/E ratio
—
P/S ratio
209.73x
EPS (TTM)
$-1.91
Dividend yield
—
52W range
$1 – $8
Volume
4.0M
Serina Therapeutics Inc (SER) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-18,478.00%
ROE
-8,159.00%
ROA
-219.60%
Debt/equity
1.82x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | $1.67M | $-15.49M | 45.32% | -764.65% | -929.89% |
| 2017 | $1.40M | $-6.58M | 51.21% | -599.50% | -468.66% |
| 2018 | $1.40M | $-7.50M | 39.76% | -748.21% | -537.39% |
| 2019 | $1.73M | $-12.15M | 42.22% | -726.79% | -703.36% |
| 2020 | $54000.00 | $-10.87M | -2,272.22% | -19,272.22% | -20,120.37% |
| 2021 | $3.46M | $-1.26M | -9.64% | -47.09% | -36.50% |
| 2022 | $500000.00 | $-2.68M | 100.00% | -454.07% | -536.42% |
| 2023 | $3.15M | $5.27M | 97.15% | -99.24% | 167.11% |
| 2024 | $56000.00 | $-11.14M | -246.43% | -30,442.86% | -19,894.64% |
| 2025 | $130000.00 | $-19.18M | 34.62% | -18,478.46% | -14,755.38% |